Publications


Technology Status Evaluation Reports

Technology status evaluation reports provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Reports are based on an evaluation of medical literature and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided. Technology status evaluation reports are scientific reviews based on expert consensus and are provided solely for educational and informational purposes.

The members of the ASGE Technology Committee provide ongoing conflict of interest (COI) disclosures throughout the development and publication of all documents in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published
Upper Endoscopy
All assessments
RETs
PIVIs

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Colonoscopy
All assessments
PIVIs

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Bariatric Endoscopy
All assessments
RETs
PIVIs

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
ERCP
EUS
All assessments
RETs

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219

EUS-guided portal vein interventions 2017

Oct 12, 2017, 16:28
EUS combines real-time imaging and minimally invasive therapeutic capabilities. Vascular access and therapy are an emerging application for EUS-based interventions.1 The proximity of vessels to the GI tract enables detailed visualization and an alternative port of entry to conventional femoral, jugular, or subclavian approaches.1, 2 EUS, with its unique view and access to the portal vein (PV), has the potential to expand our diagnostic and therapeutic armamentarium in both benign and malignant conditions. Previous studies have confirmed the feasibility of EUS-guided PV imaging and access.3, 4, 5, 6, 7, 8 This document reviews the various potential applications for EUS-guided PV interventions including staging of hepatocellular carcinoma, sampling PV blood for circulating tumor cells in pancreaticobiliary malignancies, targeted drug delivery to the liver, PV angiography and pressure measurement, creation of portosystemic shunts, and selective PV embolization in patients with liver metastases, as shown in Table 1. Prepared by: ASGE Technology Committee, Guru Trikudanathan, MD , Rahul Pannala, MD, MPH , Manoop S. Bhutani, MD, FASGE , Joshua Melson, MD , Udayakumar Navaneethan, MD , Mansour A. Parsi, MD, MPH, FASGE , Nirav Thosani, MD , Arvind J. Trindade, MD , Rabindra R. Watson, MD , John T. Maple, DO, FASGE (Chair) PlumX Metrics
Title : EUS-guided portal vein interventions 2017
URL :
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.02.019
Volume : Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888
Select a choice : Keep
Content created : May 18, 2017, 00:00
ExternalPK :
File size :
Categories :
  • Endoscopic Ultrasound (EUS)
Tags :
PIIS0016510717301219
Endoscope Design/Reprocessing
All assessments 
RETs
Other Imaging Techniques
All assessments
RETs
Therapeutic GI Devices
All assessments
RETs
Miscellaneous
All assessments
RETs

Submucosal injection fluid and tattoo agents 2024

Nov 5, 2024, 11:24
Title : Submucosal injection fluid and tattoo agents 2024
URL :
Doi org link : https://www.giejournal.org/article/S0016-5107(24)03347-9/fulltext
Volume : Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002
Select a choice : Keep
Content created :
ExternalPK :
File size :
Categories :
Tags :
  • misc

In Progress Technology Assessments

Endoscopic closure devices

2025

iStock-1189305225(1)

Practice Guidelines

View all